Linked Life Data

16326228

Source:http://linkedlifedata.com/resource/pubmed/id/16326228

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2005-12-5
pubmed:abstractText
Our understanding of the pathophysiology and clinical consequences of atrial fibrillation has led to an evidence-based revolution in the management of atrial fibrillation over the last decade. As we improve in our ability to detect recurrent atrial fibrillation and treat it definitively, the patients who benefit from long-term anticoagulation may change. We can expect, however,that stroke prevention through systemic anticoagulation will be a cornerstone of atrial fibrillation management for decades to come. Innovations in anticoagulation therapy will make the use of these medications safer. Finally, as we further understand the underlying mechanisms of the development of atrial fibrillation, the pursuit of preventative therapy will be an investigational focus of great import.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0095-4543
pubmed:author
pubmed:issnType
Print
pubmed:volume
32
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1083-107
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Atrial fibrillation.
pubmed:affiliation
Brown Medical School, Providence, RI 02912, USA.
pubmed:publicationType
Journal Article, Review